Merck & Co., Inc. (MRK) News Today $80.94 +1.61 (+2.03%) As of 11:36 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Why is Merck & Co., Inc. Up Today?Merck & Co., Inc. (NYSE:MRK) saw its shares move today on news spanning regulatory approvals, trial readouts and an analyst update. U.S. FDA approved Merck’s ENFLONSIA™ (clesrovimab-cfor) for prevention of RSV lower respiratory tract disease in infants, enabling an early launch ahead of the fall/winter RSV season and ramping up competition with Sanofi and AstraZeneca. Positive topline Phase 3 CORALreef trial results showed enlicitide decanoate met its primary cholesterol‐lowering endpoint in adults with hyperlipidemia, enhancing Merck’s cardiovascular drug prospects. Cantor Fitzgerald raised its FY2026 EPS estimate for MRK to $9.62 per share versus the $9.01 consensus, reflecting stronger expected profitability. Despite the EPS upgrade, Cantor Fitzgerald kept a “Cautious” rating on the stock, suggesting analysts remain conservative on Merck’s near-term outlook. Posted 2h agoAI Generated. May Contain Errors. MRK Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Merck's Cholesterol Lowering Drug Hits Primary Goal In Two Pivotal TrialsJune 10 at 10:47 AM | finance.yahoo.comCantor Fitzgerald Estimates MRK FY2026 EarningsMerck & Co., Inc. (NYSE:MRK - Free Report) - Research analysts at Cantor Fitzgerald issued their FY2026 earnings per share estimates for Merck & Co., Inc. in a report released on Monday, June 9th. Cantor Fitzgerald analyst C. Gould anticipates that the company will post earnings of $9.62 per sharJune 10 at 8:56 AM | marketbeat.comMerck & Co., Inc. (NYSE:MRK) Shares Acquired by Sarasin & Partners LLPSarasin & Partners LLP increased its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 4.3% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 926,650 shares of the company's stock after buying aJune 10 at 8:55 AM | marketbeat.comHandelsbanken Fonder AB Cuts Stake in Merck & Co., Inc. (NYSE:MRK)Handelsbanken Fonder AB lessened its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 43.0% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,765,174 shares of the company's stock after selling 1,332,476 shares during the quarterJune 10 at 8:28 AM | marketbeat.comAvanza Fonder AB Has $20.30 Million Position in Merck & Co., Inc. (NYSE:MRK)Avanza Fonder AB reduced its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 14.3% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 234,452 shares of the company's stock after selling 39,001 shares during the period. MJune 10 at 7:38 AM | marketbeat.comMerck & Co., Inc. (NYSE:MRK) Shares Sold by Abacus FCF Advisors LLCAbacus FCF Advisors LLC lowered its position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 43.3% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 70,249 shares of the company's stock after selling 53,554 sharesJune 10 at 7:37 AM | marketbeat.comFirst National Bank of Mount Dora Trust Investment Services Lowers Position in Merck & Co., Inc. (NYSE:MRK)First National Bank of Mount Dora Trust Investment Services trimmed its position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 68.2% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 15,603 shares of the company'June 10 at 7:28 AM | marketbeat.comLivforsakringsbolaget Skandia Omsesidigt Cuts Position in Merck & Co., Inc. (NYSE:MRK)Livforsakringsbolaget Skandia Omsesidigt lessened its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 43.5% during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 19,677 shares of the company's stock after selling 15June 10 at 7:06 AM | marketbeat.comSimplicity Wealth LLC Increases Holdings in Merck & Co., Inc. (NYSE:MRK)Simplicity Wealth LLC grew its holdings in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 991.7% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 33,394 shares of the company's stock after acquiriJune 10 at 6:48 AM | marketbeat.comCardinal Capital Management Inc. Boosts Stock Position in Merck & Co., Inc. (NYSE:MRK)Cardinal Capital Management Inc. grew its stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 15.5% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 266,606 shares of theJune 10 at 6:11 AM | marketbeat.comMerck & Co., Inc. (NYSE:MRK) Shares Sold by Yousif Capital Management LLCYousif Capital Management LLC lowered its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 2.9% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 280,249 shares of the company's stock after selling 8,292 shares duringJune 10 at 6:11 AM | marketbeat.comFarther Finance Advisors LLC Raises Stake in Merck & Co., Inc. (NYSE:MRK)Farther Finance Advisors LLC raised its position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 60.8% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 40,160 shares of the company's stockJune 10 at 5:51 AM | marketbeat.comJune 9 at 4:52 PM | gurufocus.comFDA approves Merck's RSV shot for infants, ramping up competition with Sanofi and AstaZenecaJune 9 at 3:30 PM | cnbc.comUS FDA approves Merck's RSV antibody for infantsJune 9 at 3:16 PM | reuters.comU.S. FDA Approves Merck's ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Born During or Entering Their First RSV SeasonJune 9 at 3:11 PM | businesswire.comMerck's cholesterol drug meets main goal in two studiesJune 9 at 1:36 PM | msn.comTounjian Advisory Partners LLC Purchases New Position in Merck & Co., Inc. (NYSE:MRK)Tounjian Advisory Partners LLC purchased a new stake in Merck & Co., Inc. (NYSE:MRK - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 23,186 shares of the company's stock, valued at appJune 9 at 8:29 AM | marketbeat.comMerck & Co., Inc. (NYSE:MRK) Shares Purchased by Pallas Capital Advisors LLCPallas Capital Advisors LLC raised its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 96.8% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 98,833 shares of the company's stock after acquiring an addiJune 9 at 8:28 AM | marketbeat.comCity Holding Co. Sells 6,688 Shares of Merck & Co., Inc. (NYSE:MRK)City Holding Co. lessened its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 28.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 16,672 shares of the company's stock after selling 6,688 shares during the quarter. CJune 9 at 8:16 AM | marketbeat.comDaymark Wealth Partners LLC Sells 16,535 Shares of Merck & Co., Inc. (NYSE:MRK)Daymark Wealth Partners LLC decreased its stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 7.4% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 206,520 shares of the company's stock afJune 9 at 8:00 AM | marketbeat.comMerck Announces Positive Topline Results From the First Two Phase 3 CORALreef Trials Evaluating ...June 9 at 7:31 AM | gurufocus.comBaldwin Wealth Partners LLC MA Raises Position in Merck & Co., Inc. (NYSE:MRK)Baldwin Wealth Partners LLC MA raised its stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 1.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 200,550 shares of the company's stoJune 9 at 7:05 AM | marketbeat.comFoundation Resource Management Inc. Acquires 59,369 Shares of Merck & Co., Inc. (NYSE:MRK)Foundation Resource Management Inc. increased its holdings in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 46.8% in the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 186,197 shares of the company's stock after purchasingJune 9 at 7:03 AM | marketbeat.comMerck's cholesterol drug meets main goal in late-stage studiesJune 9 at 6:59 AM | reuters.comMerck & Co., Inc. (NYSE:MRK) Shares Sold by Wesbanco Bank Inc.Wesbanco Bank Inc. lowered its position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 3.2% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 356,459 shares of the company's stock after selling 11,960 shares during the quarter. Merck & Co., Inc.June 9 at 6:49 AM | marketbeat.comMerck Announces Positive Topline Results From the First Two Phase 3 CORALreef Trials Evaluating Enlicitide Decanoate for the Treatment of Adults With HyperlipidemiaJune 9 at 6:45 AM | businesswire.comFirst Citizens Bank & Trust Co. Acquires 33,378 Shares of Merck & Co., Inc. (NYSE:MRK)First Citizens Bank & Trust Co. raised its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 67.0% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 83,216 shares of the company's stock after acquiring an additional 3June 9 at 6:39 AM | marketbeat.comWedmont Private Capital Decreases Stock Position in Merck & Co., Inc. (NYSE:MRK)Wedmont Private Capital cut its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 44.2% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 19,836 shares of the company's stock after selling 15,726 shJune 9 at 5:32 AM | marketbeat.comBank of America Securities Reaffirms Their Buy Rating on Merck & Company (MRK)June 8 at 10:24 PM | theglobeandmail.comCapital Investment Advisors LLC Increases Stake in Merck & Co., Inc. (NYSE:MRK)Capital Investment Advisors LLC raised its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 5.1% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 336,947 shares of the company's stock after acquiring an additional 1June 8 at 8:59 AM | marketbeat.comCentral Bank & Trust Co. Sells 5,146 Shares of Merck & Co., Inc. (NYSE:MRK)Central Bank & Trust Co. trimmed its position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 10.0% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 46,092 shares of theJune 8 at 8:52 AM | marketbeat.comOLD National Bancorp IN Has $11.04 Million Stock Position in Merck & Co., Inc. (NYSE:MRK)OLD National Bancorp IN boosted its position in Merck & Co., Inc. (NYSE:MRK - Free Report) by 5.5% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 122,960 shares of the company's stock after purchasing an additional 6,429 shares during the period. OLD National BJune 8 at 8:07 AM | marketbeat.comWynn Capital LLC Boosts Stake in Merck & Co., Inc. (NYSE:MRK)Wynn Capital LLC grew its position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 53.4% during the first quarter, according to its most recent filing with the SEC. The firm owned 32,489 shares of the company's stock after acquiring an additional 11,310 shares during the period. Merck &June 8 at 7:42 AM | marketbeat.comKMG Fiduciary Partners LLC Has $4.84 Million Stake in Merck & Co., Inc. (NYSE:MRK)KMG Fiduciary Partners LLC boosted its position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 7.4% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 53,952 shares of the company's stock after aJune 8 at 7:42 AM | marketbeat.comMerck & Co., Inc. (NYSE:MRK) Stock Position Decreased by Bank of New HampshireBank of New Hampshire cut its position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 50.8% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,116 shares of the company's stock after selliJune 8 at 7:23 AM | marketbeat.comMiracle Mile Advisors LLC Boosts Stock Position in Merck & Co., Inc. (NYSE:MRK)Miracle Mile Advisors LLC boosted its stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 9.5% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 101,107 shares of the company's stock after purchaJune 8 at 6:59 AM | marketbeat.comARS Wealth Advisors Group LLC Grows Stock Holdings in Merck & Co., Inc. (NYSE:MRK)ARS Wealth Advisors Group LLC raised its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 3.1% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 160,088 shares of the company's stock after buying an additioJune 8 at 6:59 AM | marketbeat.comUMB Bank n.a. Sells 17,879 Shares of Merck & Co., Inc. (NYSE:MRK)UMB Bank n.a. cut its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 10.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 148,274 shares of the company's stock after selling 17,879 shares duringJune 8 at 6:22 AM | marketbeat.comPerennial Advisors LLC Invests $370,000 in Merck & Co., Inc. (NYSE:MRK)Perennial Advisors LLC acquired a new position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 4,124 shares of the company's stock, valued at approximaJune 8 at 6:14 AM | marketbeat.comGodsey & Gibb Inc. Acquires 22,125 Shares of Merck & Co., Inc. (NYSE:MRK)Godsey & Gibb Inc. boosted its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 11.9% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 208,129 shares of the company's stock afterJune 7 at 8:08 AM | marketbeat.comPrinceton Global Asset Management LLC Sells 4,093 Shares of Merck & Co., Inc. (NYSE:MRK)Princeton Global Asset Management LLC decreased its position in Merck & Co., Inc. (NYSE:MRK - Free Report) by 30.3% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 9,394 shares of the company's sJune 7 at 7:56 AM | marketbeat.comGateway Investment Advisers LLC Has $55.25 Million Position in Merck & Co., Inc. (NYSE:MRK)Gateway Investment Advisers LLC boosted its stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 11.0% during the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 615,565 shares of the company's stock after purchasing an additional 6June 7 at 7:40 AM | marketbeat.comTealwood Asset Management Inc. Sells 6,326 Shares of Merck & Co., Inc. (NYSE:MRK)Tealwood Asset Management Inc. cut its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 20.2% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 24,919 shares of the company's stock after selling 6,June 7 at 6:56 AM | marketbeat.comMerck & Co., Inc. (NYSE:MRK) is Radnor Capital Management LLC's Largest PositionRadnor Capital Management LLC reduced its position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 2.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 507,498 shares of the company'June 7 at 6:38 AM | marketbeat.comMerck & Co., Inc. (NYSE:MRK) Shares Purchased by Vest Financial LLCVest Financial LLC raised its position in Merck & Co., Inc. (NYSE:MRK - Free Report) by 223.6% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 39,342 shares of the company's stock after purchasing an addiJune 7 at 4:53 AM | marketbeat.comShould You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?June 7 at 4:30 AM | fool.comMerck & Co., Inc. (NYSE:MRK) Stock Price Up 1.7% - Still a Buy?Merck & Co., Inc. (NYSE:MRK) Stock Price Up 1.7% - What's Next?June 6, 2025 | marketbeat.comSeaCrest Wealth Management LLC Sells 3,993 Shares of Merck & Co., Inc. (NYSE:MRK)SeaCrest Wealth Management LLC reduced its stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 11.7% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 30,127 shares of the company's stock after selling 3,99June 6, 2025 | marketbeat.comProcyon Advisors LLC Has $4.10 Million Stock Holdings in Merck & Co., Inc. (NYSE:MRK)Procyon Advisors LLC boosted its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 15.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 45,651 shares of the company's stock after purchasing an additioJune 6, 2025 | marketbeat.com Get Merck & Co., Inc. News Delivered to You Automatically Sign up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter. Email Address MRK Media Mentions By Week MRK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRK News Sentiment▼1.340.68▲Average Medical News Sentiment MRK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRK Articles This Week▼7051▲MRK Articles Average Week Get Merck & Co., Inc. News Delivered to You Automatically Sign up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Eli Lilly and Company News Johnson & Johnson News AbbVie News Pfizer News Bristol-Myers Squibb News Zoetis News Royalty Pharma News Corcept Therapeutics News Jazz Pharmaceuticals News Perrigo News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:MRK) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersTrump’s Wealth Reset: Could You Be The First Beneficiary?Trump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredWhy 2026 will be a disaster for many Americans2025 Market Crash The first-quarter stock crash left investors wondering what lies ahead. Today 50-year Wal...Chaikin Analytics | SponsoredElon’s “Secret Mission”Tesla, SpaceX and Starlink made billions for investors... But a meeting Elon had on March 21st, 2025, could...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merck & Co., Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Merck & Co., Inc. With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MRK Stock Free MRK Stock Alerts